申请人:Coowar Djalil
公开号:US20110144194A1
公开(公告)日:2011-06-16
Compounds of general formula (I) and (II) in which R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
, R
13
, R
14
and R
15
have the meanings given in the specification, are useful in the treatment of neurodegenerative disease.
通式(I)和(II)的化合物,其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12、R13、R14和R15的含义如规范中所述,对于治疗神经退行性疾病是有用的。